RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: Triple-Drug combo under study
Disease control Recruiting nowThis study tests a new combination of three drugs (mitoxantrone, cytarabine, and venetoclax) for adults whose acute myeloid leukemia has come back or not responded to earlier treatment. The goal is to see if this combination can help more patients achieve remission. About 72 part…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
New hope for hard-to-treat leukemia: experimental drug combo enters human testing
Disease control Recruiting nowThis study tests a new drug called lisaftoclax, given alone or with other medicines, for people whose acute myeloid leukemia (AML) has returned or not improved after standard treatments. The main goals are to check safety and find the best dose. About 682 adults will take part. T…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 26, 2026 11:28 UTC